Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
HONE
14051
CALL
DELISTED
HarborOne Bancorp
HONE
| $2.37K | ﹤0.01% |
200
-100
| -33% | -$1.27K |
2024 Q2
2 quarters
|
|
14052
CALL
InnovAge Holding
INNV
$1.23B
| $2.36K | ﹤0.01% |
+600
| New | +$3.11K |
2024 Q4
0 quarters
|
|
14053
CALL
RF Industries
RFIL
$91.7M
| $2.35K | ﹤0.01% |
600
-13,100
| -96% | -$53K |
2024 Q2
2 quarters
|
|
14054
PUT
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$117M
| $2.35K | ﹤0.01% |
+100
| New | +$2.49K |
2024 Q4
0 quarters
|
|
|
FLIC
14055
CALL
DELISTED
First of Long Island Corp
FLIC
| $2.34K | ﹤0.01% |
200
-1,100
| -85% | -$14.7K |
2022 Q4
8 quarters
|
|
|
FLIC
14056
PUT
DELISTED
First of Long Island Corp
FLIC
| $2.34K | ﹤0.01% |
200
-2,000
| -91% | -$26.7K |
2022 Q4
8 quarters
|
|
14057
PUT
NLI Holdings
NL
$343M
| $2.33K | ﹤0.01% |
300
-3,300
| -92% | -$26.1K |
2021 Q4
12 quarters
|
|
14058
PUT
Vor Biopharma
VOR
$1.11B
| $2.33K | ﹤0.01% |
105
+100
| +2,000% | +$1.66K |
2024 Q3
1 quarter
|
|
14059
PUT
Vivid Seats
SEAT
$39.9M
| $2.31K | ﹤0.01% |
25
-9,095
| -100% | -$678K |
2022 Q4
8 quarters
|
|
14060
CALL
Ampco-Pittsburgh
AP
$200M
| $2.3K | ﹤0.01% |
+1,100
| New | +$2.09K |
2024 Q4
0 quarters
|
|
|
ILLRW
14061
Triller Group Inc Warrant
ILLRW
$651K
| $2.29K | ﹤0.01% |
15,719
-33,498
| -68% | -$5.94K |
2024 Q1
3 quarters
|
|
|
PVBC
14062
CALL
DELISTED
Provident Bancorp
PVBC
| $2.28K | ﹤0.01% |
200
-2,000
| -91% | -$22.1K |
2023 Q1
7 quarters
|
|
14063
Apollomics Inc Warrant
APLMW
$940K
| $2.27K | ﹤0.01% |
244,676
-62,572
| -20% | -$695 |
2023 Q4
4 quarters
|
|
|
EMX
14064
PUT
DELISTED
EMX Royalty
EMX
| $2.25K | ﹤0.01% |
1,300
+500
| +63% | +$895 |
2022 Q4
8 quarters
|
|
14065
CALL
Ovid Therapeutics
OVID
$459M
| $2.24K | ﹤0.01% |
2,400
-35,000
| -94% | -$39.2K |
2023 Q4
4 quarters
|
|
14066
CALL
Crown Crafts
CRWS
$26.4M
| $2.24K | ﹤0.01% |
+500
| New | +$2.31K |
2024 Q4
0 quarters
|
|
|
PARAA
14067
PUT
DELISTED
Paramount Global Class A
PARAA
| $2.23K | ﹤0.01% |
100
-2,600
| -96% | -$58K |
2024 Q2
2 quarters
|
|
14068
CALL
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.16B
| $2.22K | ﹤0.01% |
100
-300
| -75% | -$6.93K |
2023 Q3
5 quarters
|
|
14069
BT Brands Warrant
BTBDW
$36K
| $2.21K | ﹤0.01% |
23,778
-3,025
| -11% | -$239 |
2024 Q2
2 quarters
|
|
|
PRO
14070
PUT
DELISTED
PROS Holdings
PRO
| $2.2K | ﹤0.01% |
100
-800
| -89% | -$17.2K |
2023 Q3
5 quarters
|
|
|
MSPRZ
14071
DELISTED
MSP Recovery Inc Warrant
MSPRZ
| $2.19K | ﹤0.01% |
44,598
+2,362
| +6% | +$157 |
2024 Q2
2 quarters
|
|
|
QVCGA
14072
CALL
DELISTED
QVC Group Inc Series A
QVCGA
| $2.18K | ﹤0.01% |
132
+60
| +83% | +$1.4K |
2019 Q2
22 quarters
|
|
|
AGEN
14073
Agenus
AGEN
$378M
| $2.16K | ﹤0.01% |
788
-19,252
| -96% | -$71.3K |
2024 Q3
1 quarter
|
|
14074
PUT
IBEX
IBEX
$579M
| $2.15K | ﹤0.01% |
100
-900
| -90% | -$17.7K |
2024 Q3
1 quarter
|
|
|
IRD
14075
PUT
Opus Genetics
IRD
$380M
| $2.14K | ﹤0.01% |
1,800
+1,000
| +125% | +$1.15K |
2022 Q4
8 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.